FIELD: biotechnology, food and medicinal industry. SUBSTANCE: invention proposes the consortium of bifidobacteria and lactobacilli Bifidobacterium bifidum 1, B. bifidum 791, B. breve 79-119, B. breve 79-88, B. infantis 73-15, B. infantis 79-43, Lactobacillus plantarum 8-RA-3, L. fermentum 90-TS-4, GKNM MNIIEM named for G.N. Gabritchevsky, N 159 used for preparing bacterial preparations, ferments for fermented-milk foodstuffs, fermented and nonfermented foodstuffs, biologically active supplements designated for correction of microflora in children in age below 3 years. The consortium is designated for correction of intestine microflora, mucous, opened cavities, cutaneous integuments in children of age below 3 years. The strain shows immunocorrecting action and provides the enhanced protective, immunotrophic, metabolic and digestive functions because of synergetic effect of bifidobacteria and lactobacilli as components of its composition that stimulates the growth of normal microflora. EFFECT: expanded arsenal of technical agents of curative-prophylaxis designation. 3 tbl, 5 ex
Authors
Dates
2002-03-27—Published
2001-04-28—Filed